Furthermore, PC therapy has been shown to modulate the tumor microenvironment by reducing immunosuppressive cells such as regulatory T cells and myeloid-derived suppressor cells, and by increasing the infiltration and activation of effector CD8+ T cells. Here, CD8A is linked to neoplasm.